Randomised clinical trials (RCTs) remain the gold standard in evaluating therapeutic interventions, ensuring that treatment effects are not confounded by systematic errors. Central to these trials is ...

Standardizing the strategy in glioblastoma trials to promote success in cell and gene therapy clinical development.

When considering a sequence of therapy for a patient with metastatic breast cancer, oncologists rely heavily on clinical trial data. Sometimes, however, clinical trial data may not be as reliable as ...